슬롯 꽁 머니’s next-generation immuno-oncology technology featured as a cover article in international journal

[by Ji, Yong Jun] 슬롯 꽁 머니 announced on February 20 that a study demonstrating a significant improvement in cancer treatment efficacy by combining 'cancer stem cell-targeting immunotherapy technology' and 'high-intensity focused ultrasound technology' was selected as the cover article for the January issue of the international academic journal 'Pharmaceutics'.

The research paper was chosen as the cover article of Pharmaceutics after a thorough review by the 슬롯 꽁 머니’s editors, standing out among 138 published studies in the same issue. This recognition underscores the global significance and innovative potential of combining cancer stem cell-targeting immunotherapy with high-intensity focused ultrasound technology. The breakthrough is expected to attract considerable interest from major global pharmaceutical companies.

Pharmaceutics is a well-known international academic 슬롯 꽁 머니 specializing in pharmaceuticals and biopharmaceutics. Published as an open-access (peer-reviewed) 슬롯 꽁 머니 by MDPI, it covers a wide range of research areas, including drug formulation design, drug delivery systems, bioavailability improvement, and nanopharmacology. The 슬롯 꽁 머니 is indexed in major academic databases such as Scopus, PubMed, and Web of Science (SCIE).

This study was jointly conducted by 슬롯 꽁 머니 CEO Seong Seung-yong and researchers from Seoul National University College of Medicine. The company emphasized that the research is drawing attention not only for its potential to overcome the limitations of current single-modality cancer treatments and improving anticancer treatments to a new level but also for its groundbreaking implications in treating intractable metastatic cancers.

In the study, 슬롯 꽁 머니 developed a therapeutic approach that boosts the immune response by combining high-intensity focused ultrasound with anticancer immune cell vaccines. This approach demonstrated a dual effect of physically removing the primary tumor with high-intensity focused ultrasound while simultaneously controlling the tumor microenvironment and inhibiting metastatic cancer growth using a tumor-targeting immune vaccine. Notably, preclinical results showed a 93.9% reduction in metastatic tumor growth in a mouse model and a decrease in cancer recurrence risk by targeting cancer stem cell-specific antigens.

The treatment’s theoretical foundation is based on the concept of ‘DAMPs (Damage Associated Molecular Patterns),’ introduced by CEO Seong in ‘Nature Reviews Immunology’ in 2004. By using high-intensity focused ultrasound, the production of DAMPs in 슬롯 꽁 머니ous tissues can be artificially increased. These DAMPs activate immune cells in the body, significantly boosting the capacity to target and eliminate 슬롯 꽁 머니 cells, including metastatic ones.

“This research is receiving attention from the global academic and industrial communities as a revolutionary treatment that effectively removes the cancer stem cells, thereby suppressing the immune response and increasing resistance to immunotherapy,” a 슬롯 꽁 머니 official said. “The technology is currently being explored in conjunction with 슬롯 꽁 머니’s developing nanobody anticancer treatment, accelerating the development of a new and differentiated approach to cancer treatment.”